Results 71 to 80 of about 6,713 (180)
Endocrinology Research and Practice, 2019 Objective: The risk for atherosclerosis increases in hypothyroidism, although its associated mode of pathogenesis has not been determined yet. Paraoxonase1 (PON1) is an enzyme that is antioxidative and antiatherogenic. This study was planned to determine
Ayşen CANİKLİOĞLU +7 more
doaj +1 more source
Trakya University Journal of Natural SciencesBackground: Streptozotocin (STZ) is an agent with selective toxicity targeting pancreatic β-cells and is commonly used to establish models of pancreatic damage.
Selcen Çakır
doaj +1 more source
Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
Iranian Journal of Allergy, Asthma and Immunology, 2015 Oxidative stress is involved in the pathogenesis of asthma. Paraoxonase 1 (PON1) and arylesterase are esterase enzymes displaying antioxidant characteristics.
Nurhan Sarioglu +4 more
doaj
The importance of paraoxonase 1 activity in chronic kidney disease
Renal FailureParaoxonase 1 (PON1) is one of the most significant antioxidative enzymes associated with high-density lipoprotein (HDL). It has been proved that is involved in the pathogenesis of many diseases including chronic kidney disease (CKD).
Elisabeth C. Samouilidou +4 more
doaj +1 more source
Kinesiologia Slovenica: scientific journal on sportParaoxonase (PON) enzyme family (paraoxonase 1, 2 and 3) has antiatherosclerotic properties. The decreased PON1 enzyme activity (EA), PON1 level and PON1-L55M polymorphism (PON1P) are risk factors for atherosclerosis. Effects of anaerobic training on PON1 levels and the role of PON1P are unclear.
Sevilmis, Ezgi +6 more
openaire +2 more sources
Paraoxonase (PON1) and polymorphisms of PON1 gene
The Journal of Japan Atherosclerosis Society, 2000 Tadashi SUEIRO +4 more
openaire +2 more sources
Decreased PON1 activity as a biological marker for depressive disorders: a narrative review
Journal of Affective Disorders ReportsBackground: This study conducts a narrative review to summarize evidence regarding changes in serum/plasma paraoxonase 1 (PON1) activity in patients with major depressive disorder (MDD) or other depressive disorders and assess their possible marker value.
Oleg A. Levada, Oleksandra S. Troian
doaj +1 more source
Journal of Translational MedicineBackground Risk stratification in hepatocellular carcinoma (HCC) is limited by the lack of robust biomarkers reflecting tumor biology. The antioxidant enzyme Paraoxonase-1 (PON1) shows prognostic potential, yet its role in tumor tissues and the ...
Chiyu Cai +12 more
doaj +1 more source
Somatic Gene Therapy in the Prevention of Toxic Effects of Organophosphate Agents
Вестник войск РХБ защитыMedical intervention in poisoning by organophosphate toxic agents (OPA) using atropine sulfate, 2-pyridinaldoxymethyl chloride (2-PAM), diazepam and other similar drugs can prevent the fatal outcome of poisoning.
J. Lakota
doaj +1 more source